Protective efficacy and safety of three antimalarial regimens for the prevention of malaria in young Ugandan children: a randomized controlled trial.

Protective efficacy and safety of three antimalarial regimens for the prevention of malaria in young Ugandan children: a randomized controlled trial.

Chemoprevention offers a promising strategy for prevention of malaria in African children. However, the optimal chemoprevention drug and dosing strategy is unclear in areas of year-round transmission and resistance to many antimalarial drugs. To compare three available regimens, we conducted an open...

Full description

Bibliographic Details
Main Authors:	Victor Bigira, James Kapisi, Tamara D Clark, Stephen Kinara, Florence Mwangwa, Mary K Muhindo, Beth Osterbauer, Francesca T Aweeka, Liusheng Huang, Jane Achan, Diane V Havlir, Philip J Rosenthal, Moses R Kamya, Grant Dorsey
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-08-01
Series:	PLoS Medicine
Online Access:	http://europepmc.org/articles/PMC4122345?pdf=render

Similar Items

Factors associated with malaria parasitaemia, malnutrition, and anaemia among HIV-exposed and unexposed Ugandan infants: a cross-sectional survey
by: Osterbauer Beth, et al.
Published: (2012-12-01)

Polymorphisms in K13 and falcipain-2 associated with artemisinin resistance are not prevalent in Plasmodium falciparum isolated from Ugandan children.
by: Melissa D Conrad, et al.
Published: (2014-01-01)

Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children
by: Kamya Moses R, et al.
Published: (2008-06-01)

Incidence of malaria and efficacy of combination antimalarial therapies over 4 years in an urban cohort of Ugandan children.
by: Tamara D Clark, et al.
Published: (2010-07-01)

Malaria burden in a birth cohort of HIV-exposed uninfected Ugandan infants living in a high malaria transmission setting
by: Abel Kakuru, et al.
Published: (2016-10-01)

Generation of a malaria negative Ugandan birth weight standard for the diagnosis of small for gestational age.
by: Arthurine K Zakama, et al.
Published: (2020-01-01)

Maternal nutritional status predicts adverse birth outcomes among HIV-infected rural Ugandan women receiving combination antiretroviral therapy.
by: Sera Young, et al.
Published: (2012-01-01)

Treatment of malaria restricted to laboratory-confirmed cases: a prospective cohort study in Ugandan children
by: Staedke Sarah, et al.
Published: (2007-01-01)

Use of the slide positivity rate to estimate changes in malaria incidence in a cohort of Ugandan children
by: Kamya Moses R, et al.
Published: (2009-09-01)

Efficacy, safety, and tolerability of three regimens for prevention of malaria: a randomized, placebo-controlled trial in Ugandan schoolchildren.
by: Joaniter Nankabirwa, et al.
Published: (2010-10-01)

Population pharmacokinetics and pharmacodynamics of lumefantrine in young Ugandan children treated with artemether-lumefantrine for uncomplicated malaria
by: Tchaparian, E, et al.
Published: (2016)

Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline
by: Oriana Kreutzfeld, et al.
Published: (2023-06-01)

Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants.
by: Creek, D, et al.
Published: (2013)

Antimalarial pharmacokinetics and treatment regimens.
by: White, N
Published: (1992)

Marked reduction in antibiotic usage following intensive malaria control in a cohort of Ugandan children
by: Paul J. Krezanoski, et al.
Published: (2021-11-01)

Relationships between infection with Plasmodium falciparum during pregnancy, measures of placental malaria, and adverse birth outcomes
by: James Kapisi, et al.
Published: (2017-10-01)

Quality of inpatient pediatric case management for four leading causes of child mortality at six government-run Ugandan hospitals.
by: David Sears, et al.
Published: (2015-01-01)

Monitoring antimalarial safety and tolerability in clinical trials: A case study from Uganda
by: Mpimbaza Arthur, et al.
Published: (2008-06-01)

Antimalarial dosing regimens and drug resistance.
by: Barnes, K, et al.
Published: (2008)

DRUG-DRUG INTERACTIONS BETWEEN ARTEMETHER/LUMEFANTRINE AND LOPINAVIR/RITONAVIR IN HIV NEGATIVE HEALTHY VOLUNTEERS
by: German, P, et al.
Published: (2008)

The association between malnutrition and the incidence of malaria among young HIV-infected and -uninfected Ugandan children: a prospective study
by: Arinaitwe Emmanuel, et al.
Published: (2012-03-01)

Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda
by: Dorsey Grant, et al.
Published: (2009-11-01)

Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children.
by: Liusheng Huang, et al.
Published: (2017-01-01)

Diversity of KIR genes and their HLA-C ligands in Ugandan populations with historically varied malaria transmission intensity
by: Stephen Tukwasibwe, et al.
Published: (2021-02-01)

Hepatotoxicity due to a drug interaction between amodiaquine plus artesunate and efavirenz
by: German, P, et al.
Published: (2007)

Hepatotoxicity due to a drug interaction between amodiaquine plus artesunate and efavirenz.
by: German, P, et al.
Published: (2007)

Impact of adverse events of antiretroviral treatment on regimen change and mortality in Ugandan children
by: Ntambwe Malangu, et al.
Published: (2010-06-01)

The impact of gravidity, symptomatology and timing of infection on placental malaria
by: Erin E. Tran, et al.
Published: (2020-06-01)

Acceptability of routine HIV counselling and testing, and HIV seroprevalence in Ugandan hospitals
by: Rhoda K Wanyenze, et al.
Published: (2008-04-01)

The Effect of Dosing Regimens on the Antimalarial Efficacy of Dihydroartemisinin-Piperaquine: A Pooled Analysis of Individual Patient Data
by: Achan, J, et al.
Published: (2013)

Mid-level managers’ perspectives on implementing isoniazid preventive therapy for people living with HIV in Ugandan health districts: a qualitative study
by: Canice Christian, et al.
Published: (2024-03-01)

Lopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteers.
by: German, P, et al.
Published: (2009)

Increasing incidence of malaria in children despite insecticide-treated bed nets and prompt anti-malarial therapy in Tororo, Uganda
by: Jagannathan Prasanna, et al.
Published: (2012-12-01)

Longitudinal study of urban malaria in a cohort of Ugandan children: description of study site, census and recruitment
by: Staedke Sarah G, et al.
Published: (2006-03-01)

Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children
by: Kamya Moses, et al.
Published: (2009-01-01)

Hypertension control in integrated HIV and chronic disease clinics in Uganda in the SEARCH study
by: Dalsone Kwarisiima, et al.
Published: (2019-05-01)

Determination of unbound piperaquine in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry
by: Liusheng Huang, et al.
Published: (2022-11-01)

Interplay among malnutrition, chemoprevention, and the risk of malaria in young Ugandan children: Longitudinal pharmacodynamic and growth analysis
by: Ali Mohamed Ali, et al.
Published: (2023-05-01)

Adherence to Antihypertensive Medication: An Interview Analysis of Southwest Ugandan Patients’ Perspectives
by: Josephine Nambi Najjuma, et al.
Published: (2020-06-01)

Efficacy of quinine, artemether-lumefantrine and dihydroartemisinin-piperaquine as rescue treatment for uncomplicated malaria in Ugandan children.
by: Adoke Yeka, et al.
Published: (2013-01-01)